257 related articles for article (PubMed ID: 21151441)
1. 3D-QSAR and molecular docking studies on derivatives of MK-0457, GSK1070916 and SNS-314 as inhibitors against Aurora B kinase.
Zhang B; Li Y; Zhang H; Ai C
Int J Mol Sci; 2010 Nov; 11(11):4326-47. PubMed ID: 21151441
[TBL] [Abstract][Full Text] [Related]
2. 3D-QSAR and molecular docking studies of azaindole derivatives as Aurora B kinase inhibitors.
Lan P; Chen WN; Sun PH; Chen WM
J Mol Model; 2011 May; 17(5):1191-205. PubMed ID: 20697761
[TBL] [Abstract][Full Text] [Related]
3. Exploration of the structural requirements of Aurora Kinase B inhibitors by a combined QSAR, modelling and molecular simulation approach.
Ashraf S; Ranaghan KE; Woods CJ; Mulholland AJ; Ul-Haq Z
Sci Rep; 2021 Sep; 11(1):18707. PubMed ID: 34548506
[TBL] [Abstract][Full Text] [Related]
4. Combined 3D-QSAR modeling and molecular docking studies on pyrrole-indolin-2-ones as Aurora A kinase inhibitors.
Ai Y; Wang ST; Sun PH; Song FJ
Int J Mol Sci; 2011; 12(3):1605-24. PubMed ID: 21673910
[TBL] [Abstract][Full Text] [Related]
5. Computational investigation of imidazo[2,1-b]oxazole derivatives as potential mutant BRAF kinase inhibitors: 3D-QSAR, molecular docking, molecular dynamics simulation, and ADMETox studies.
Boutalaka M; El Bahi S; Alaqarbeh M; El Alaouy MA; Koubi Y; Khatabi KE; Maghat H; Bouachrine M; Lakhlifi T
J Biomol Struct Dyn; 2024 Jul; 42(10):5268-5287. PubMed ID: 37424193
[TBL] [Abstract][Full Text] [Related]
6. Probing the structural requirements of A-type Aurora kinase inhibitors using 3D-QSAR and molecular docking analysis.
Zhang HX; Li Y; Wang X; Wang YH
J Mol Model; 2012 Mar; 18(3):1107-22. PubMed ID: 21670994
[TBL] [Abstract][Full Text] [Related]
7.
Shirvani P; Fassihi A
J Biomol Struct Dyn; 2022 Aug; 40(13):5965-5982. PubMed ID: 33475043
[TBL] [Abstract][Full Text] [Related]
8. Molecular modeling studies on imidazo[4,5-b]pyridine derivatives as Aurora A kinase inhibitors using 3D-QSAR and docking approaches.
Lan P; Chen WN; Chen WM
Eur J Med Chem; 2011 Jan; 46(1):77-94. PubMed ID: 21093113
[TBL] [Abstract][Full Text] [Related]
9. 3D-QSAR (CoMFA, CoMFA-RG, CoMSIA) and molecular docking study of thienopyrimidine and thienopyridine derivatives to explore structural requirements for aurora-B kinase inhibition.
Borisa A; Bhatt H
Eur J Pharm Sci; 2015 Nov; 79():1-12. PubMed ID: 26343315
[TBL] [Abstract][Full Text] [Related]
10. In silico design novel (5-imidazol-2-yl-4-phenylpyrimidin-2-yl)[2-(2-pyridylamino)ethyl]amine derivatives as inhibitors for glycogen synthase kinase 3 based on 3D-QSAR, molecular docking and molecular dynamics simulation.
He Q; Han C; Li G; Guo H; Wang Y; Hu Y; Lin Z; Wang Y
Comput Biol Chem; 2020 Oct; 88():107328. PubMed ID: 32688011
[TBL] [Abstract][Full Text] [Related]
11. P56(lck) kinase inhibitor studies: a 3D QSAR approach towards designing new drugs from flavonoid derivatives.
Gunda SK; Narasimha SK; Shaik M
Int J Comput Biol Drug Des; 2014; 7(2-3):278-94. PubMed ID: 24878734
[TBL] [Abstract][Full Text] [Related]
12. Combined 3D-QSAR, molecular docking and molecular dynamics study on derivatives of peptide epoxyketone and tyropeptin-boronic acid as inhibitors against the β5 subunit of human 20S proteasome.
Liu J; Zhang H; Xiao Z; Wang F; Wang X; Wang Y
Int J Mol Sci; 2011; 12(3):1807-35. PubMed ID: 21673924
[TBL] [Abstract][Full Text] [Related]
13. Studies on [5,6]-Fused Bicyclic Scaffolds Derivatives as Potent Dual B-RafV600E/KDR Inhibitors Using Docking and 3D-QSAR Approaches.
Liu HC; Tang SZ; Lu S; Ran T; Wang J; Zhang YM; Xu AY; Lu T; Chen YD
Int J Mol Sci; 2015 Oct; 16(10):24451-74. PubMed ID: 26501259
[TBL] [Abstract][Full Text] [Related]
14. 3D-QSAR, molecular dynamics simulations, and molecular docking studies on pyridoaminotropanes and tetrahydroquinazoline as mTOR inhibitors.
Chaube U; Bhatt H
Mol Divers; 2017 Aug; 21(3):741-759. PubMed ID: 28577112
[TBL] [Abstract][Full Text] [Related]
15. Structural determinants of benzodiazepinedione/peptide-based p53-HDM2 inhibitors using 3D-QSAR, docking and molecular dynamics.
Wang F; Li Y; Ma Z; Wang X; Wang Y
J Mol Model; 2012 Jan; 18(1):295-306. PubMed ID: 21523548
[TBL] [Abstract][Full Text] [Related]
16. Design of Novel Chemotherapeutic Agents Targeting Checkpoint Kinase 1 Using 3D-QSAR Modeling and Molecular Docking Methods.
Balupuri A; Balasubramanian PK; Cho SJ
Curr Comput Aided Drug Des; 2016; 12(4):302-313. PubMed ID: 27585602
[TBL] [Abstract][Full Text] [Related]
17. Molecular docking and 3D-QSAR study on 4-(1H-indazol-4-yl) phenylamino and aminopyrazolopyridine urea derivatives as kinase insert domain receptor (KDR) inhibitors.
Wu X; Wu S; Chen WH
J Mol Model; 2012 Mar; 18(3):1207-18. PubMed ID: 21695506
[TBL] [Abstract][Full Text] [Related]
18. Molecular modeling studies of 4,5-dihydro-1H-pyrazolo[4,3-h] quinazoline derivatives as potent CDK2/Cyclin a inhibitors using 3D-QSAR and docking.
Ai Y; Wang ST; Sun PH; Song FJ
Int J Mol Sci; 2010 Sep; 11(10):3705-24. PubMed ID: 21152296
[TBL] [Abstract][Full Text] [Related]
19. Docking-Based 3D-QSAR Studies for 1,3,4-oxadiazol-2-one Derivatives as FAAH Inhibitors.
Zięba A; Laitinen T; Patel JZ; Poso A; Kaczor AA
Int J Mol Sci; 2021 Jun; 22(11):. PubMed ID: 34204026
[TBL] [Abstract][Full Text] [Related]
20. Molecular Modeling Studies on Carbazole Carboxamide Based BTK Inhibitors Using Docking and Structure-Based 3D-QSAR.
Li R; Du Y; Gao Z; Shen J
Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29671827
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]